PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Ann: Phase 2 Synovial Fluid Biomarker Study Update, page-65

  1. 360 Posts.
    lightbulb Created with Sketch. 47
    I too like your post, thanks
    There are many reservations in my mind, for instance -
    As a double blind placebo study looking for 60 participants -
    30 turned up
    how many pulled out before day 56?
    is it assumed from the start, every 2nd participant gets the Zilosul, remember it's randomized?
    there may actually be less, rather than 15, or conversely more because it's randomized.
    Thank goodness I'm in for the long haul!
    Cheers, Skip

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.